Filtros de búsqueda

Lista de obras de Michael Hudecek

A highly soluble Sleeping Beauty transposase improves control of gene insertion

scientific article published on 04 November 2019

Adoptive T-cell therapy for B-cell malignancies

artículo científico publicado en 2009

Adoptive therapy with chimeric antigen receptor-modified T cells of defined subset composition

artículo científico

CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients

artículo científico publicado en 2016

Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo

artículo científico publicado en 2015

Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia

scientific article published on 30 June 2009

Engineered T cells for anti-cancer therapy.

artículo científico publicado en 2012

Enhanced CAR T-cell engineering using non-viral Sleeping Beauty transposition from minicircle vectors

artículo científico publicado en 2016

Expression of programmed death-1 on lymphocytes in myeloma patients is lowered during lenalidomide maintenance

artículo científico publicado en 2017

Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells

artículo científico publicado en 2016

Inefficient CAR-proximal signaling blunts antigen sensitivity

artículo científico publicado en 2020

Kleine Antigene – große Wirkung

artículo científico publicado en 2008

Mesenchymal Stem Cells Remain Host-Derived Independent of the Source of the Stem-Cell Graft and Conditioning Regimen Used

artículo científico publicado en 2009

Minicircle-Based Engineering of Chimeric Antigen Receptor (CAR) T Cells.

artículo científico publicado en 2016

Mining Naïve Rabbit Antibody Repertoires by Phage Display for Monoclonal Antibodies of Therapeutic Utility

artículo científico

Myeloma CARs are rolling into the clinical arena

artículo científico publicado en 2016

Panobinostat induces CD38 upregulation and augments the antimyeloma efficacy of daratumumab

artículo científico publicado en 2017

Receptor affinity and extracellular domain modifications affect tumor recognition by ROR1-specific chimeric antigen receptor T cells

scientific article published on 25 April 2013

Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells.

artículo científico publicado en 2009

SLAMF7-CAR T cells eliminate myeloma and confer selective fratricide of SLAMF7+ normal lymphocytes

artículo científico publicado en 2017

Safety of targeting ROR1 for cancer immunotherapy with chimeric antigen receptor-modified T cells in a primate model

artículo científico publicado en 2014

Safety of targeting ROR1 in primates with chimeric antigen receptor-modified T cells

artículo científico publicado en 2014

Spontaneous remission of acute myeloid leukemia relapse after hematopoietic cell transplantation in a high-risk patient with 11q23/MLL abnormality

artículo científico publicado en 2008

Targeted antibody-mediated depletion of murine CD19 CAR T cells permanently reverses B cell aplasia

scientific article published on 17 October 2016

The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.

artículo científico publicado en 2010

The nonsignaling extracellular spacer domain of chimeric antigen receptors is decisive for in vivo antitumor activity.

artículo científico publicado en 2014

The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells

scientific article published on 01 July 2019